Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.
AIDS
Africa
HIV
HIV subtype
epidemiology
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
02 07 2019
02 07 2019
Historique:
received:
21
09
2018
accepted:
22
03
2019
pubmed:
3
4
2019
medline:
3
4
2019
entrez:
3
4
2019
Statut:
ppublish
Résumé
Few human immunodeficiency virus (HIV)-infected persons can maintain low viral levels without therapeutic intervention. We evaluate predictors of spontaneous control of the viral load (hereafter, "viral control") in a prospective cohort of African adults shortly after HIV infection. Viral control was defined as ≥2 consecutively measured viral loads (VLs) of ≤10 000 copies/mL after the estimated date of infection, followed by at least 4 subsequent measurements for which the VL in at least 75% was ≤10 000 copies/mL in the absence of ART. Multivariable logistic regression characterized predictors of viral control. Of 590 eligible volunteers, 107 (18.1%) experienced viral control, of whom 25 (4.2%) maintained a VL of 51-2000 copies/mL, and 5 (0.8%) sustained a VL of ≤50 copies/mL. The median ART-free follow-up time was 3.3 years (range, 0.3-9.7 years). Factors independently associated with control were HIV-1 subtype A (reference, subtype C; adjusted odds ratio [aOR], 2.1 [95% confidence interval {CI}, 1.3-3.5]), female sex (reference, male sex; aOR, 1.8 [95% CI, 1.1-2.8]), and having HLA class I variant allele B*57 (reference, not having this allele; aOR, 1.9 [95% CI, 1.0-3.6]) in a multivariable model that also controlled for age at the time of infection and baseline CD4+ T-cell count. We observed strong associations between infecting HIV-1 subtype, HLA type, and sex on viral control in this cohort. HIV-1 subtype is important to consider when testing and designing new therapeutic and prevention technologies, including vaccines.
Identifiants
pubmed: 30938435
pii: 5425476
doi: 10.1093/infdis/jiz127
pmc: PMC6603968
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
432-441Subventions
Organisme : Medical Research Council
ID : MC_UU_00027/1
Pays : United Kingdom
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI051231
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI064060
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
AIDS. 2009 Jul 17;23(11):1397-404
pubmed: 19381076
AIDS Res Hum Retroviruses. 2011 Jan;27(1):5-12
pubmed: 21091377
EBioMedicine. 2016 Nov;13:305-314
pubmed: 27751765
AIDS. 1999 Oct 1;13(14):1990-1
pubmed: 10513667
J Infect Dis. 2002 May 1;185(9):1244-50
pubmed: 12001041
AIDS. 2014 Jan 14;28(2):149-62
pubmed: 24149086
PLoS One. 2015 Jan 20;10(1):e0116100
pubmed: 25602351
PLoS One. 2014 Jul 03;9(7):e101475
pubmed: 24992306
J Virol. 2002 Aug;76(16):8276-84
pubmed: 12134033
AIDS. 2009 Nov 27;23(18):2479-84
pubmed: 19841572
AIDS. 2017 Nov 28;31(18):2541-2546
pubmed: 29028659
Pathol Biol (Paris). 2006 Dec;54(10):566-71
pubmed: 17027185
Sci Rep. 2018 Apr 17;8(1):6111
pubmed: 29666450
Hum Genet. 2014 Sep;133(9):1187-97
pubmed: 24969460
AIDS. 2005 Nov 18;19(17):2001-7
pubmed: 16260907
Virology. 2009 Mar 15;385(2):416-24
pubmed: 19157481
Annu Rev Med. 2012;63:131-45
pubmed: 22248321
AIDS. 2014 Jan 14;28(2):235-43
pubmed: 24413311
Sci Rep. 2015 Jun 17;5:11253
pubmed: 26082240
Virology. 2014 Jan 20;449:254-62
pubmed: 24418560
Cell Mol Life Sci. 2013 Mar;70(6):1009-19
pubmed: 22864624
J Virol. 2013 Jan;87(2):708-15
pubmed: 23115285
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
AIDS. 2013 Nov 13;27(17):2775-86
pubmed: 24113395
Science. 2014 Jul 11;345(6193):1254031
pubmed: 25013080
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):394-398
pubmed: 30063647
J Infect Dis. 1999 Jan;179(1):68-73
pubmed: 9841824
Adv Virus Res. 1999;53:71-88
pubmed: 10582095
J Virol. 2016 Jul 11;90(15):6818-6831
pubmed: 27194762
J Virol. 2011 Sep;85(17):8894-902
pubmed: 21715491
PLoS One. 2009;4(2):e4401
pubmed: 19197365
AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):901-10
pubmed: 11461676
J Infect Dis. 2009 Dec 1;200(11):1714-23
pubmed: 19852669
J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):403-8
pubmed: 19214118